Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases
出版年份 2013 全文链接
标题
Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases
作者
关键词
-
出版物
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Volume 78, Issue 2, Pages 130-139
出版商
Wiley
发表日期
2013-05-14
DOI
10.1111/sji.12069
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease
- (2013) Rakesh Bam et al. AMERICAN JOURNAL OF HEMATOLOGY
- The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
- (2013) Girija Dasmahapatra et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dasatinib plus Capecitabine for Advanced Breast Cancer: Safety and Efficacy in Phase I Study CA180004
- (2013) G. Somlo et al. CLINICAL CANCER RESEARCH
- Current and Emerging Therapies in Mantle Cell Lymphoma
- (2013) L. Kyle Brett et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
- (2013) Jan A. Burger et al. LEUKEMIA & LYMPHOMA
- Dual Phosphorylation of Btk by Akt/Protein Kinase B Provides Docking for 14-3-3ζ, Regulates Shuttling, and Attenuates both Tonic and Induced Signaling in B Cells
- (2013) Dara K. Mohammad et al. MOLECULAR AND CELLULAR BIOLOGY
- Ibrutinib (PCI-32765), the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials
- (2013) Jennifer R. Brown Current Hematologic Malignancy Reports
- X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase
- (2012) Larry R. McLean et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- BTK inhibition in myeloma: targeting the seed and the soil
- (2012) C. M. Edwards BLOOD
- Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
- (2012) Y.-T. Tai et al. BLOOD
- Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
- (2012) Yibin Yang et al. CANCER CELL
- Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders
- (2012) Tadeusz Robak et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dasatinib for the treatment of Philadelphia chromosome-positive leukemias
- (2012) Fabio P S Santos et al. EXPERT OPINION ON PHARMACOTHERAPY
- A novel BTK-like protein involved in immune response in Lethenteron japonicum
- (2012) Fenfang Wu et al. IMMUNOLOGY LETTERS
- Glucocorticosteroids Rescue Basophils from Dasatinib-Augmented Immunoglobulin E-Mediated Histamine Release
- (2012) Harald Herrmann et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Bruton Tyrosine Kinase (BTK) and Its Role in B-cell Malignancy
- (2012) Joseph J. Buggy et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases
- (2012) R M Linka et al. LEUKEMIA
- Regulation of Nucleocytoplasmic Shuttling of Bruton's Tyrosine Kinase (Btk) through a Novel SH3-Dependent Interaction with Ankyrin Repeat Domain 54 (ANKRD54)
- (2012) M. O. Gustafsson et al. MOLECULAR AND CELLULAR BIOLOGY
- Differential Evolutionary Wiring of the Tyrosine Kinase Btk
- (2012) Hossain M. Nawaz et al. PLoS One
- Optimisation of ITK inhibitors through successive iterative design cycles
- (2011) Matthias Herdemann et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
- (2011) S. E. M. Herman et al. BLOOD
- The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
- (2011) S. Ponader et al. BLOOD
- Dasatinib combined with docetaxel for castration-resistant prostate cancer
- (2011) John C. Araujo et al. CANCER
- Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2011) P. C. Amrein et al. CLINICAL CANCER RESEARCH
- TEC family kinases in health and disease - loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK
- (2011) Alamdar Hussain et al. FEBS Journal
- Tec family kinases Itk and Rlk / Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates
- (2011) Julio Gomez-Rodriguez et al. FEBS Journal
- Tec family kinases: Itk signaling and the development of NKT αβ and γδ T cells
- (2011) Qian Qi et al. FEBS Journal
- Bruton's Tyrosine Kinase Is Required for TLR-Dependent Heme Oxygenase-1 Gene Activation via Nrf2 in Macrophages
- (2011) V. Vijayan et al. JOURNAL OF IMMUNOLOGY
- Discovery and Structure−Activity Relationship of 3-Aminopyrid-2-ones as Potent and Selective Interleukin-2 Inducible T-Cell Kinase (Itk) Inhibitors
- (2011) Jean-Damien Charrier et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
- (2011) Betty Y Chang et al. ARTHRITIS RESEARCH & THERAPY
- Synthesis and biological evaluation of novel (4 or 5-aryl)pyrazolyl-indoles as inhibitors of interleukin-2 inducible T-cell kinase (ITK)
- (2010) Avdhoot D. Velankar et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases
- (2010) Arne von Bonin et al. EXPERIMENTAL DERMATOLOGY
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Primary B Cell Immunodeficiencies: Comparisons and Contrasts
- (2009) Mary Ellen Conley et al. Annual Review of Immunology
- 5-Aminomethylbenzimidazoles as potent ITK antagonists
- (2009) Doris Riether et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily
- (2009) C. Sillaber et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Tec protein tyrosine kinase inhibits CD25 expression in human T-lymphocyte
- (2009) Kentaro Susaki et al. IMMUNOLOGY LETTERS
- Girls homozygous for an IL-2–inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation
- (2009) Kirsten Huck et al. JOURNAL OF CLINICAL INVESTIGATION
- 5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)
- (2008) Michael P. Winters et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Itk kinase inhibitors: Initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead
- (2008) Kevin J. Moriarty et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design
- (2008) Brian N. Cook et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils
- (2008) M. Kneidinger et al. BLOOD
- The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes
- (2008) A. Veldurthy et al. BLOOD
- Clinical Potential of Targeting Bruton's Tyrosine Kinase
- (2008) Fatih M. Uckun INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Selective targeting of ITK blocks multiple steps of HIV replication
- (2008) J. A. Readinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now